UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $136,808 | +40.4% | 9,765 | +3.7% | 0.00% | 0.0% |
Q2 2023 | $97,466 | +16.0% | 9,417 | -2.8% | 0.00% | – |
Q1 2022 | $84,000 | -15.2% | 9,685 | -6.6% | 0.00% | – |
Q4 2021 | $99,000 | -45.0% | 10,367 | -2.9% | 0.00% | -100.0% |
Q3 2021 | $180,000 | +7.8% | 10,676 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $167,000 | -24.1% | 10,930 | -3.2% | 0.00% | 0.0% |
Q1 2021 | $220,000 | +8.4% | 11,296 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $203,000 | -9.4% | 11,267 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $224,000 | -27.7% | 11,591 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $310,000 | +56.6% | 11,853 | +6.9% | 0.00% | 0.0% |
Q1 2020 | $198,000 | -49.5% | 11,091 | -5.5% | 0.00% | -50.0% |
Q4 2019 | $392,000 | +39.0% | 11,733 | -0.8% | 0.00% | +100.0% |
Q3 2019 | $282,000 | -34.1% | 11,831 | -0.7% | 0.00% | -50.0% |
Q2 2019 | $428,000 | – | 11,913 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |